Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eggstein, S
Right arrow Articles by Farthmann, E H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eggstein, S
Right arrow Articles by Farthmann, E H
Gut 1999;44:834-838 ( June )

Article

Expression and activity of mitogen activated protein kinases in human colorectal carcinoma S Eggstein, M Franke, I Kutschka, G Manthey, B U von Specht, G Ruf, E H Farthmann

Department of General Surgery, University of Freiburg, Freiburg, Germany

Correspondence to: Dr S Eggstein, Chirurgische Universitätsklinik Freiburg, Abteilung Allgemeine Chirurgie mit Poliklinik, Hugstetterstrasse 55, D-79106 Freiburg, Germany.

Accepted for publication 13 January 1999

BACKGROUND---Mitogen activated protein kinases (MAPKs) play a central role in the regulation of both cell growth and differentiation. They are involved in signal transduction of oncogenes and growth factors. The role of MAPK in colonic carcinoma is unknown.
AIMS---To establish whether the expression and activity of p42/44 MAPKs are altered in colorectal tumours as compared with normal mucosa.
METHODS---The expression and activity of p42/p44 MAPK were investigated in 22 colorectal carcinomas, four adenomas, and the corresponding normal colorectal mucosa by the use of western blotting, immunoprecipitation, and in vitro kinase assays.
RESULTS---After immunoprecipitation with an antibody specific for p42 MAPK, we found significant inactivation of p42 MAPK in colonic carcinomas as well as in adenomas, whereas most sample pairs showed only minor differences in p42 MAPK expression. Investigation of MAPK with an antibody capable of detecting both p42 and p44 MAPK showed a slight but significant decrease in p44 MAPK content in malignant tissues. With this antibody, only minor alterations in MAPK activity and no correlation with p42 MAPK activity were found.
CONCLUSIONS---Inactivation of p42 MAPK could be associated with colonic carcinogenesis.


Keywords: mitogen activated protein kinase (MAPK); Raf-1; colorectal cancer

© 1999 by Gut


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M.-J. Boucher, D. Jean, A. Vezina, and N. Rivard
Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G736 - G746.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology